Literature DB >> 19441990

Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine.

Elena Pirola1, Francesco Vergani, Paolo Casiraghi, Eugenio Biagio Leone, Paolo Guerra, Erik Pietro Sganzerla.   

Abstract

Phosphaturic mesenchymal tumors that cause the paraneoplastic syndrome known as oncogenic osteomalacia are rare. The authors report on the case of a 57-year-old man with a history of osteomalacia and in whom was diagnosed a thoracic spine tumor at the T-4 level. Complete tumor resection was accomplished. The histological diagnosis was phosphaturic mesenchymal tumor (mixed connective tissue variant). After lesion removal, the paraneoplastic syndrome resolved. At the 24-month follow-up, no recurrence of the disease was observed. The clinical presentation, surgical technique, and follow-up in this case were reviewed in detail.

Entities:  

Mesh:

Year:  2009        PMID: 19441990     DOI: 10.3171/2009.1.SPINE08351

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  9 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

2.  Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia.

Authors:  Regina S Bower; Wilson P Daugherty; Caterina Giannini; Ian F Parney
Journal:  Surg Neurol Int       Date:  2012-12-14

Review 3.  En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review.

Authors:  Tong Meng; Wang Zhou; Bo Li; Huabin Yin; Zhenxi Li; Lei Zhou; Jinhai Kong; Wangjun Yan; Xinghai Yang; Tielong Liu; Dianwen Song; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2015-05-08       Impact factor: 2.754

4.  Tumor-induced hypophosphatemia.

Authors:  M Mulani; K Somani; S Bichu; V Billa
Journal:  Indian J Nephrol       Date:  2017 Jan-Feb

5.  Primary phosphaturic mesenchymal tumour of the lumbar spine: utility of 68Ga-DOTATOC PET/CT findings.

Authors:  Junki Maehara; Koji Yamashita; Akio Hiwatashi; Osamu Togao; Kazufumi Kikuchi; Yoshihiro Matsumoto; Kunio Iura; Yoshinao Oda; Isao Ichino; Yuji Nakamoto; Hiroshi Honda
Journal:  BJR Case Rep       Date:  2016-11-02

6.  Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Weibo Xia; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: a case report.

Authors:  Isao Chokyu; Kenichi Ishibashi; Takeo Goto; Kenji Ohata
Journal:  J Med Case Rep       Date:  2012-07-02

8.  Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report.

Authors:  Gunjan Y Gandhi; Aashish A Shah; Kevin J Wu; Vivek Gupta; Ali Reza Shoraka
Journal:  Case Rep Endocrinol       Date:  2012-12-17

9.  Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.